📢

donate.tpfund.org/team/481709

Dear friends, the horrifying earthquake disaster and it’s aftermath is impacting current and future lives of children. Please support this project seeking to generate long term solutions to this devastating problem. #CATE

Publication alert 🚨I am thrilled to share the final paper from my PhD! Check out our new story with Susanne Wolf and Bilge Ugursu : Sex-specific #microglia state in the Neuroligin-4 knock-out mouse model of #autismspectrumdisorder in BrainBehavImm ! doi.org/10.1016/j.bbi.…

I may have played the tiniest role in the actual project, but I have been part of the entire emotional roller-coaster of this story since 2014 😅 I'm so happy to see it finally published, and so proud of you Dilansu Güneykaya ! Huge congratulations to everyone involved!

"Bullying is a means for mediocre scientists to rise to the top. Some star academics reached their position because they are bullies, not in spite of it." - Excellent piece about bullying in academia (and really any other professional environment). nature.com/articles/s4156…

Super excited to be here at #CIMT2023 after 4 years. Looking forward to connecting with some old friends!

The Sim lab is now real and we're officially hiring! I recently got an MRC Fellowship and am now recruiting a Research Assistant and a PostDoc very soon. RA job is live: shorturl.at/HRSX9 Come to Oxford and do cool science on NK cells and KIR. Please share!

One man's niche is another man's treasure 😀

Boston Türk Biyologlar Kolokyumu’nun (BTBC) yeni akademik dönemdeki ilk buluşmasına Başkonsolosluk konutumuzda evsahipliği yapmaktan mutlu olduk. Son derece başarılı genç bilim insanlarımızı BTBC’de bir araya getiren Prof. Gökhan Hotamışlıgil’e Gökhan Hotamışlıgil teşekkürler. 🇹🇷 🔬

We presented a positive data update for our #CARTcell therapy candidate BNT211 in advanced solid tumors at ESMO - Eur. Oncology Congress 2023. Our goal is to help improve the outcomes for a broad range of hard-to-treat tumors. Read more about the data update here: investors.biontech.de/news-releases/…

I am very happy to share our most recent article describing a novel strategy to detect and visualize immune synapses between antigen presenting cells and T cells. elifesciences.org/articles/91809 #elife #tcells #immunology Ohio State Rheumatology Pelotonia Institute for Immuno-Oncology AkkayaLab 2.0 Billur Akkaya

In Pfizer's Superbowl commercial I appear together with scientists including, Galileo, Copernicus, Newton, Einstein, Marie Maynard Daly and Rosalind Franklin 💫🎉 It can't be better than that youtube.com/watch?v=fwvjim…

Happy International Women's Day! We're celebrating women who have changed the world. Here's all of the amazing women who have received the #NobelPrize and their remarkable achievements at the time of the award. Who are the women who inspire you the most? #IWD2024

🚨Just published: The registration enabling clinical data set for an affinity-enhanced TCR targeting the cancer-germline antigen MAGE-4. Afami cell on track to be the *first* FDA approved TCR gene therapy and first gene therapy product for a solid cancer. thelancet.com/journals/lance…

🚨Fantastic pair of papers in nature today from Evan Weber, @MackallLab and the Darcy lab Peter Mac Cancer Centre on enforcing stem-like molecular programs in therapeutic T cells through overexpression of #FOXO1! 👇 nature.com/articles/s4158…. Children's Hospital Stanford Cancer Institute Parker Institute for Cancer Immunotherapy

Impressive results from the Rosenberg lab @NCIResearchCtr using TCR gene therapy targeting private neoantigens in patients with metastatic colorectal cancer. Tumor regression in majority of patients, including 3/7 (43%) objective responses. nature.com/articles/s4159…